Ready or not, genomic screening of fetuses is already here.
作者信息
Gold Nina B, Nadel Allan, Green Robert C
机构信息
Division of Medical Genetics and Metabolism, Massachusetts General Hospital for Children, Boston, MA; Harvard Medical School, Boston, MA.
Harvard Medical School, Boston, MA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA.
出版信息
Genet Med. 2024 Jan;26(1):101008. doi: 10.1016/j.gim.2023.101008. Epub 2023 Oct 17.
Abstract
摘要
相似文献
1
Ready or not, genomic screening of fetuses is already here.
Genet Med. 2024 Jan;26(1):101008. doi: 10.1016/j.gim.2023.101008. Epub 2023 Oct 17.
2
Prenatal genetic evaluation of fetuses with structural anomaly: is it time to shift from microarray to exome sequencing as a first-tier test?
Ultrasound Obstet Gynecol. 2023 Jan;61(1):119-120. doi: 10.1002/uog.26120.
3
Retrospective identification of prenatal fetal anomalies associated with diagnostic neonatal genomic sequencing results.
Prenat Diagn. 2022 May;42(6):705-716. doi: 10.1002/pd.6111. Epub 2022 Feb 21.
4
Advantages of current fetal neuroimaging and genomic technologies in prenatal diagnosis: A clinical case.
Eur J Med Genet. 2023 Jan;66(1):104652. doi: 10.1016/j.ejmg.2022.104652. Epub 2022 Oct 28.
5
A single center experience of prenatal parent-fetus trio exome sequencing for pregnancies with congenital anomalies.
Prenat Diagn. 2022 Jun;42(7):901-910. doi: 10.1002/pd.6170. Epub 2022 May 20.
6
Prenatal exome sequencing analysis in fetuses with central nervous system anomalies.
Ultrasound Obstet Gynecol. 2023 Nov;62(5):721-726. doi: 10.1002/uog.26254.
7
[Diagnosis of a fetus with atelosteogenesis type 2 through combined prenatal ultrasonography and whole exome sequencing].
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 Jul 10;37(7):767-770. doi: 10.3760/cma.j.issn.1003-9406.2020.07.016.
8
[Analysis of families with fetal congenital abnormalities but negative prenatal diagnosis by whole exome sequencing].
Zhonghua Fu Chan Ke Za Zhi. 2021 Jul 25;56(7):458-466. doi: 10.3760/cma.j.cn112141-20210118-00028.
9
Application of exome sequencing for prenatal diagnosis of fetal structural anomalies: clinical experience and lessons learned from a cohort of 1618 fetuses.
Genome Med. 2022 Oct 28;14(1):123. doi: 10.1186/s13073-022-01130-x.
10
Rapid prenatal diagnosis using targeted exome sequencing: a cohort study to assess feasibility and potential impact on prenatal counseling and pregnancy management.
Genet Med. 2018 Nov;20(11):1430-1437. doi: 10.1038/gim.2018.30. Epub 2018 Mar 29.
引用本文的文献
1
Advancing precision care in pregnancy through a treatable fetal findings list.
Am J Hum Genet. 2025 Jun 5;112(6):1251-1269. doi: 10.1016/j.ajhg.2025.03.011. Epub 2025 Apr 9.
2
"Knowledge was clearly associated with education." epistemic positioning in the context of informed choice: a scoping review and secondary qualitative analysis.
BMC Med Ethics. 2025 Jan 9;26(1):1. doi: 10.1186/s12910-024-01144-7.
3
Implementing genomic newborn screening as an effective public health intervention: sidestepping the hype and criticism.
NPJ Genom Med. 2024 Dec 19;9(1):70. doi: 10.1038/s41525-024-00451-7.
4
Prenatal diagnosis for neurofibromatosis type 1 and the pitfalls of germline mosaics.
NPJ Genom Med. 2024 Sep 8;9(1):41. doi: 10.1038/s41525-024-00425-9.
本文引用的文献
1
Features of Vascular Ehlers-Danlos Syndrome Among Biobank Participants Harboring Predicted High-Risk Genotypes.
Circ Genom Precis Med. 2023 Apr;16(2):e003864. doi: 10.1161/CIRCGEN.122.003864. Epub 2023 Mar 3.
2
International Society for Prenatal Diagnosis 2022 debate 3-Fetal genome sequencing should be offered to all pregnant patients.
Prenat Diagn. 2023 Apr;43(4):428-434. doi: 10.1002/pd.6247. Epub 2022 Oct 21.
3
Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
Front Genet. 2022 Jul 25;13:920390. doi: 10.3389/fgene.2022.920390. eCollection 2022.
4
Prenatal phenotyping: A community effort to enhance the Human Phenotype Ontology.
Am J Med Genet C Semin Med Genet. 2022 Jun;190(2):231-242. doi: 10.1002/ajmg.c.31989. Epub 2022 Jul 24.
5
ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: A policy statement of the American College of Medical Genetics and Genomics (ACMG).
Genet Med. 2022 Jul;24(7):1407-1414. doi: 10.1016/j.gim.2022.04.006. Epub 2022 Jun 17.
6
International Society for Prenatal Diagnosis Updated Position Statement on the use of genome-wide sequencing for prenatal diagnosis.
Prenat Diagn. 2022 May;42(6):796-803. doi: 10.1002/pd.6157.
7
Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta-analysis.
Prenat Diagn. 2022 May;42(6):662-685. doi: 10.1002/pd.6115. Epub 2022 May 7.
8
Population-Based Penetrance of Deleterious Clinical Variants.
JAMA. 2022 Jan 25;327(4):350-359. doi: 10.1001/jama.2021.23686.
9
High rate of abnormal findings in Prenatal Exome Trio in low risk pregnancies and apparently normal fetuses.
Prenat Diagn. 2022 May;42(6):725-735. doi: 10.1002/pd.6077. Epub 2021 Dec 17.
10
Your DNA is not your diagnosis: getting diagnoses right following secondary genomic findings.
Genet Med. 2016 Aug;18(8):765-7. doi: 10.1038/gim.2015.134. Epub 2015 Oct 8.
Zotero 插件